Evotec SE (EVO) Other Non-Current Assets (2009 - 2026)
Evotec SE's (EVO) quarterly Other Non-Current Assets came in at $1.3 million in Q2 2026, up 11.86% year-over-year from $1.1 million in Q2 2025, and up 160.56% quarter-over-quarter from $489371.7 in Q1 2026.
Analysis
Evotec SE (EVO) Other Non-Current Assets (2009 - 2026) Analysis & Trends
Evotec SE has disclosed Other Non-Current Assets across 9 years of filings, most recently posting $1.3 million for Q2 2026.
- In Q2 2026, Other Non-Current Assets rose 11.86% year-over-year to $1.3 million; the TTM figure through Jun 2026 stood at $1.3 million (up 11.86% YoY), while the FY2025 annual figure was $572814.3, down 84.72% from the prior year.
- Other Non-Current Assets came in at $1.3 million for Q2 2026 at Evotec SE, up from $489371.7 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $8.2 million in Q3 2024 to a low of $489371.7 in Q1 2026.
- Average Other Non-Current Assets over 5 years is $2.7 million, with a median of $1.2 million recorded in 2025.
- Year-over-year, Other Non-Current Assets surged 488.42% in 2022 and slumped 89.09% in 2025.
- Over 5 years, Other Non-Current Assets stood at $3.9 million in 2022, then slumped by 76.68% to $900561.7 in 2023, then jumped by 311.03% to $3.7 million in 2024, then sank by 84.06% to $590170.1 in 2025, then jumped by 116.06% to $1.3 million in 2026.
- Per Business Quant data, the three most recent Other Non-Current Assets figures were $1.3 million in Q2 2026, $489371.7 in Q1 2026, and $590170.1 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 42.77 Bn | 40.69 Bn | 1.44 Bn | 558.00 Mn |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn | 25.20 Mn |
| 3 | Charles River Laboratories International | 13.37 Bn | 13.18 Bn | 452.07 Mn | 587.56 Mn |
| 4 | Icon | 12.49 Bn | 11.56 Bn | 479.29 Mn | 117.41 Mn |
| 5 | Fortrea Holdings | 1.58 Bn | 1.42 Bn | 139.20 Mn | 91.80 Mn |
| 6 | Evotec SE | 642.83 Mn | 216.96 Mn | - | 1.28 Mn |
| 7 | Ginkgo Bioworks Holdings | 422.55 Mn | 338.02 Mn | 18.44 Mn | 87.48 Mn |
| 8 | Champions Oncology | 69.16 Mn | 69.16 Mn | 7.03 Mn | 212,000.00 |
| 9 | MindWalk Holdings | 59.83 Mn | 51.55 Mn | 1.82 Mn | 91,917.76 |
| 10 | VivoSim Labs | 1.45 Mn | 1.45 Mn | - | 143,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.28 Mn |
| Mar 31, 2026 | 489,371.68 |
| Dec 31, 2025 | 590,170.06 |
| Sep 30, 2025 | 889,650.92 |
| Jun 30, 2025 | 1.14 Mn |
| Mar 31, 2025 | 3.11 Mn |
| Dec 31, 2024 | 3.70 Mn |
| Sep 30, 2024 | 8.15 Mn |
| Mar 31, 2024 | 924,493.86 |
| Dec 31, 2023 | 900,561.70 |
| Dec 31, 2022 | 3.86 Mn |
| Sep 30, 2022 | 5.89 Mn |
| Jun 30, 2022 | 5.45 Mn |
| Mar 31, 2022 | 969,699.79 |
| Dec 31, 2021 | 995,254.73 |
| Sep 30, 2021 | 1.00 Mn |
| Dec 31, 2020 | 1.06 Mn |
| Sep 30, 2010 | 3.98 Mn |
| Jun 30, 2010 | 3.94 Mn |
| Mar 31, 2010 | 5,038.96 |